Lorin Johnson's most recent trade in Edesa Biotech Inc was a trade of 11,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Lorin K. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Lorin Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Lorin Johnson | Director | 09 Nov 2020 | 4,262 | 12,786 (0%) | 0% | 4 | 17,048 | Common Shares | |
| Edesa Biotech Inc | Lorin Johnson | Director | 09 Nov 2020 | 4,262 | 0 | - | - | Common Share Warrants (Right to Buy) | ||
| Edesa Biotech Inc | Lorin Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 20,000 | 20,000 | - | - | Stock option (right to buy) |